Evaluation of adherence to highly active antiretroviral therapy

Vista sencilla de ítem
dc.contributor.authorMartín Fernández, Jesús
dc.contributor.authorEscobar-Rodríguez, Ismael
dc.contributor.authorCampo-Angora, Mercedes
dc.contributor.authorRubio-García, Rafael
dc.date.accessioned2025-01-07T08:03:54Z
dc.date.available2025-01-07T08:03:54Z
dc.date.issued2001-12
dc.descriptionThis work has been supported by project 2109/00 from the Fundación para la Investigación y la Prevención del Sida en España (FIPSE), Madrid, Spain.
dc.description.abstractThe efficacy of highly active antiretroviral therapy (HAART) with regard to the morbidity and mortality of patients infected with human immunodeficiency virus (HIV) is well known. Nevertheless, this efficacy is affected at both the individual and population levels when compliance with the treatment is inadequate.1,2 Improper adherence to HAART has been related to an increase in the viral load,3-5 which is a key element in the appearance of viral resistances
dc.identifier.citationMartín-Fernández J, Escobar-Rodríguez I, Campo-Angora M, Rubio-García R. Evaluation of Adherence to Highly Active Antiretroviral Therapy. Arch Intern Med. 2001;161(22):2739–2740
dc.identifier.issn2168-6114 (online)
dc.identifier.issn2168-6106 (print)
dc.identifier.urihttps://hdl.handle.net/10115/50557
dc.language.isoen_US
dc.publisherAmerican Medical Association
dc.rights.accessRightsinfo:eu-repo/semantics/closedAccess
dc.subjectCross-Sectional Studies
dc.subjectHIV Infections / drug therapy
dc.subjectPatient Compliance
dc.subjectSensitivity and Specificity
dc.subjectAntiretroviral Therapy
dc.subjectHighly Active
dc.titleEvaluation of adherence to highly active antiretroviral therapy
dc.typeArticle

Archivos

Bloque original

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Arch_Intern_Med_2001.pdf
Tamaño:
47.76 KB
Formato:
Adobe Portable Document Format
Descargar

Colecciones

Artículos de Revista